The Limited Times

Now you can see non-English news...

Nathalie Gimenes: "Let's build a more egalitarian pharmaceutical economy"

2021-04-28T07:54:49.306Z


INTERVIEW - For the sector specialist, a more cooperative model between drug players would facilitate access to treatments in low-income countries.


After twenty-six years in the pharmaceutical industry, Nathalie Gimenes believes more than ever in corporate social responsibility (CSR), the thesis of her doctorate in management sciences.

A member of the scientific council of the Entreprise & Progrès think-tank, she has created a consulting firm that offers to reconcile profitability and contribution to the collective interest.

While the global race for the anti-Covid vaccine is underway, it invites drug companies to review their economic model.

It publishes

The Pharmaceutical Industry: Time for Choice

(L'Observatoire).

Read also:

Sacred union to relaunch antibiotics

LE FIGARO.

- Do the speed and effectiveness of vaccination against the coronavirus in the United States, Great Britain and Israel support national policies?

Nathalie GIMENES.

-

Nationalist strategies mainly serve the short-term political objectives of the rulers.

Of course, they provide an answer to the populations of these countries, with the real and media successes that we know.

This article is for subscribers only.

You have 84% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All business articles on 2021-04-28

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.